The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines

Cancer Lett. 2007 Jan 8;245(1-2):284-92. doi: 10.1016/j.canlet.2006.01.017. Epub 2006 Mar 2.

Abstract

The purpose of this study was to evaluate the effect of tamoxifen (TAM) when used in combination with cisplatin on oral squamous cell carcinoma (OSCC). For this, the relation between estrogen receptor (ER) expression level and the cytotoxic effect of TAM, the apoptotic effect and its molecular mechanisms of TAM were investigated using OSCC cell lines. Combination treatment demonstrated a superior cytotoxic and apoptotic effect on OSCC cell lines. Considerable amount of ER was detected in some OSCC cell lines, but there were no significant differences of cytotoxic effect of TAM. TAM inhibited PKC activity and up-regulated TGF-beta1 secretion.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects*
  • Blotting, Western
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cisplatin / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Flow Cytometry
  • Humans
  • Mouth Neoplasms / metabolism
  • Mouth Neoplasms / pathology
  • Protein Kinase C / metabolism
  • Receptors, Estrogen / metabolism
  • Tamoxifen / pharmacology*
  • Time Factors
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Antineoplastic Agents
  • Receptors, Estrogen
  • Transforming Growth Factor beta1
  • Tamoxifen
  • Protein Kinase C
  • Cisplatin